Effect of BDNFVal66Met on disease markers in dominantly inherited AD

OBJECTIVE. Previous studies suggest that the brain-derived neurotrophic factor (BDNF) Val66Met (rs6265) polymorphism may influence symptom onset in Alzheimer’s disease (AD). Our recent cross-sectional findings suggest that Met66 may influence clinical expression in dominantly inherited AD (DIAD) thr...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ann Neurol
Egile Nagusiak: Lim, Yen Ying, Hassenstab, Jason, Goate, Alison, Fagan, Anne M., Benzinger, Tammie L.S., Cruchaga, Carlos, McDade, Eric, Chhatwal, Jasmeer, Levin, Johannes, Farlow, Martin R., GraffRadford, Neill R., Laske, Christoph, Masters, Colin L, Salloway, Stephen, Schofield, Peter, Morris, John C., Maruff, Paul, Bateman, Randall J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6153076/
https://ncbi.nlm.nih.gov/pubmed/30014553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.25299
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak